← Back to Clinical Trials
Recruiting NCT06826365

Immune Cell Populations in the Endometrium

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Infertility, Female
Sponsor Jagiellonian University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50
Sex FEMALE
Min Age 18 Years
Max Age 45 Years
Start Date 2025-07-01
Completion 2026-06-30
Interventions
Percentage distribution of immune system cells in peripheral bloodPercentage distribution of immune system cells in endometrium

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Specialized immunological studies in the diagnostics of idiopathic infertility and recurrent miscarriages have limited applicability, as the role of the immune system in these conditions is not thoroughly understood. In ovulatory cycles, changes occur in the populations of uterine lymphocytes, which may influence the receptivity of the endometrium and the implantation of the embryo. Particularly notable are the changes in natural killer (NK) cells, which reach their peak during the luteal phase and regulate the invasion of the trophoblast. The dominant NK cells exhibit a CD56bright phenotype and differ in cytokine profiles from peripheral blood cells. Cyclical changes also affect macrophages and T lymphocytes; however, it is unclear whether their proportions differ in women with reduced fertility. There is a need to investigate how the composition of lymphocytes in blood influences the populations in the endometrium. The aim of this study is to analyze the correlation between peripheral and endometrial lymphocytes in women with idiopathic infertility and recurrent miscarriages, compared to fertile women.

Eligibility Criteria

Inclusion Criteria: * age 18-45 years * idiopathic infertility * at least 2 miscarriages * other benign gynecological conditions subjected to endometrial sampling Exclusion Criteria: * miscarriage within last 3 months * abdominal/uterine surgery within last 3 months * viral/bacterial infection within last 3 months * antibiotic therapy within last 3 months

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}